Literature DB >> 24706837

In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift.

John Halliday1, Karim Helmy, Siobhan S Pattwell, Kenneth L Pitter, Quincey LaPlant, Tatsuya Ozawa, Eric C Holland.   

Abstract

Glioblastoma is the most common adult primary brain tumor and has a dismal median survival. Radiation is a mainstay of treatment and significantly improves survival, yet recurrence is nearly inevitable. Better understanding the radiation response of glioblastoma will help improve strategies to treat this devastating disease. Here, we present a comprehensive study of the in vivo radiation response of glioma cells in a mouse model of proneural glioblastoma. These tumors are a heterogeneous mix of cell types with differing radiation sensitivities. To explicitly study the gene expression changes comprising the radiation response of the Olig2(+) tumor bulk cells, we used translating ribosome affinity purification (TRAP) from Olig2-TRAP transgenic mice. Comparing both ribosome-associated and total pools of mRNA isolated from Olig2(+) cells indicated that the in vivo gene expression response to radiation occurs primarily at the total transcript level. Genes related to apoptosis and cell growth were significantly altered. p53 and E2F were implicated as major regulators of the radiation response, with p53 activity needed for the largest gene expression changes after radiation. Additionally, radiation induced a marked shift away from a proneural expression pattern toward a mesenchymal one. This shift occurs in Olig2(+) cells within hours and in multiple genetic backgrounds. Targets for Stat3 and CEBPB, which have been suggested to be master regulators of a mesenchymal shift, were also up-regulated by radiation. These data provide a systematic description of the events following radiation and may be of use in identifying biological processes that promote glioma radioresistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24706837      PMCID: PMC3986190          DOI: 10.1073/pnas.1321014111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

Authors:  Krishna P L Bhat; Veerakumar Balasubramaniyan; Brian Vaillant; Ravesanker Ezhilarasan; Howard Colman; Erik P Sulman; Kenneth Aldape; Karlijn Hummelink; Faith Hollingsworth; Khalida Wani; Lindsey Heathcock; Johanna D James; Lindsey D Goodman; Siobhan Conroy; Lihong Long; Nina Lelic; Suzhen Wang; Joy Gumin; Divya Raj; Yoshinori Kodama; Aditya Raghunathan; Adriana Olar; Kaushal Joshi; Christopher E Pelloski; Amy Heimberger; Se Hoon Kim; Daniel P Cahill; Ganesh Rao; Wilfred F A Den Dunnen; Hendrikus W G M Boddeke; Heidi S Phillips; Ichiro Nakano; Frederick F Lang
Journal:  Cancer Cell       Date:  2013-08-29       Impact factor: 31.743

2.  Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes.

Authors:  Xing Lü; Lorena de la Peña; Christopher Barker; Kevin Camphausen; Philip J Tofilon
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

3.  mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Authors:  Xiaoyi Hu; Pier Paolo Pandolfi; Yi Li; Jason A Koutcher; Marc Rosenblum; Eric C Holland
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.

Authors:  David Dornan; Mirjam Eckert; Maura Wallace; Harumi Shimizu; Eleanor Ramsay; Ted R Hupp; Kathryn L Ball
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

Authors:  June L Chan; Susan W Lee; Benedick A Fraass; Daniel P Normolle; Harry S Greenberg; Larry R Junck; Stephen S Gebarski; Howard M Sandler
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

Review 7.  Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.

Authors:  J B Demoulin; J C Renauld
Journal:  Cytokines Cell Mol Ther       Date:  1998-12

8.  Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

Authors:  S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

9.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

Review 10.  Malignant glioma--a nemesis which requires clinical and basic investigation in radiation oncology.

Authors:  L W Davis
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

View more
  68 in total

Review 1.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 2.  NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.

Authors:  G Kenneth Gray; Braden C McFarland; Susan E Nozell; Etty N Benveniste
Journal:  Expert Rev Neurother       Date:  2014-09-29       Impact factor: 4.618

3.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

4.  Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.

Authors:  C J Herting; Z Chen; K L Pitter; F Szulzewsky; I Kaffes; M Kaluzova; J C Park; P J Cimino; C Brennan; B Wang; D Hambardzumyan
Journal:  Glia       Date:  2017-08-24       Impact factor: 7.452

5.  The angiogenic switch leads to a metabolic shift in human glioblastoma.

Authors:  Krishna M Talasila; Gro V Røsland; Hanne R Hagland; Eskil Eskilsson; Irene H Flønes; Sabrina Fritah; Francisco Azuaje; Nadia Atai; Patrick N Harter; Michel Mittelbronn; Michael Andersen; Justin V Joseph; Jubayer Al Hossain; Laurent Vallar; Cornelis J F van Noorden; Simone P Niclou; Frits Thorsen; Karl Johan Tronstad; Charalampos Tzoulis; Rolf Bjerkvig; Hrvoje Miletic
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

6.  Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.

Authors:  Sung-Hak Kim; Ravesanker Ezhilarasan; Emma Phillips; Daniel Gallego-Perez; Amanda Sparks; David Taylor; Katherine Ladner; Takuya Furuta; Hemragul Sabit; Rishi Chhipa; Ju Hwan Cho; Ahmed Mohyeldin; Samuel Beck; Kazuhiko Kurozumi; Toshihiko Kuroiwa; Ryoichi Iwata; Akio Asai; Jonghwan Kim; Erik P Sulman; Shi-Yuan Cheng; L James Lee; Mitsutoshi Nakada; Denis Guttridge; Biplab DasGupta; Violaine Goidts; Krishna P Bhat; Ichiro Nakano
Journal:  Cancer Cell       Date:  2016-02-08       Impact factor: 31.743

Review 7.  EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.

Authors:  Eskil Eskilsson; Gro V Røsland; Gergely Solecki; Qianghu Wang; Patrick N Harter; Grazia Graziani; Roel G W Verhaak; Frank Winkler; Rolf Bjerkvig; Hrvoje Miletic
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

8.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

9.  STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma.

Authors:  Jasmine Lau; Shirin Ilkhanizadeh; Susan Wang; Yekaterina A Miroshnikova; Nicolas A Salvatierra; Robyn A Wong; Christin Schmidt; Valerie M Weaver; William A Weiss; Anders I Persson
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

10.  Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.

Authors:  Liting Deng; Lindsay Ng; Tatsuya Ozawa; Nephi Stella
Journal:  J Pharmacol Exp Ther       Date:  2016-11-07       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.